ARTICLE | Company News
Conpharm, Meda sales and marketing update
January 31, 2000 8:00 AM UTC
MEDA will market in Nordic and Baltic countries CONP's Reumacon, a mixture of two benzylidenated podophyllotoxin glucosides that is under review in Sweden. ...